Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETIHX:US

24.81 USD 0.26 1.04%

As of 09:29:30 ET on 04/17/2015.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETIHX)

Year To Date: +17.86% 3-Month: +14.91% 3-Year: - 52-Week Range: 14.38 - 25.21
1-Month: +0.69% 1-Year: +57.42% 5-Year: - Beta vs SPX: 0.84

Mutual Fund Chart for ETIHX

No chart data available.
  • ETIHX:US 24.81
  • 1M
  • 1Y
Interactive ETIHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETIHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETIHX

NAV (on 2015-04-17) 24.81
Assets (M) (on 2015-04-17) 234.53
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 50.00

Dividends for ETIHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETIHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.43

Top Fund Holdings for ETIHX

Filing Date: 12/31/2014
Name Position Value % of Total
Fidelity Institutional Money M 19,554,386 19,554,386 13.100%
Bluebird Bio Inc 71,200 6,530,464 4.375%
Veracyte Inc 592,400 5,722,584 3.834%
Tetraphase Pharmaceuticals Inc 139,000 5,519,690 3.698%
Five Prime Therapeutics Inc 163,900 4,425,300 2.965%
Chimerix Inc 106,600 4,291,716 2.875%
Dyax Corp 303,000 4,260,180 2.854%
Agios Pharmaceuticals Inc 34,400 3,854,176 2.582%
Medivation Inc 36,300 3,615,843 2.422%
Cempra Inc 153,800 3,615,838 2.422%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil